Announced

Completed

Yonsung Group completed the acquisition of Arevipharma.

Synopsis

Yonsung Group, a Korean supplier of Prostaglandin products, completed its acquisition of Arevipharma, a modern manufacturer of active pharmaceutical ingredients and intermediate products. Financial terms were not disclosed. Through this transaction, the parties will expand and internationalize Arevipharma's active ingredient business and innovate and invest in its Radebeul production site.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

All rights reserved. Copyright © 2025 Datasite